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Abstract: Genes that increase susceptibility to age-related macular degeneration (AMD) 
have been identified; however, since many individuals carrying these risk alleles do not 
develop disease, other contributors are involved. One additional factor, long implicated in 
the pathogenesis of AMD, is the lipofuscin of retinal pigment epithelium (RPE). The 
fluorophores that constitute RPE lipofuscin also serve as a source of autofluorescence (AF) 
that can be imaged by confocal laser ophthalmoscopy. The AF originating from lipofuscin 
is excited by the delivery of short wavelength (SW) light. A second autofluorescence is 
emitted from the melanin of RPE (and choroid) upon near-infrared (NIR-AF) excitation. 
SW-AF imaging is currently used in the clinical management of retinal disorders and the 
advantages of NIR-AF are increasingly recognized. Here we visit the damaging properties 
of RPE lipofuscin that could be significant when expressed on a background of genetic 
susceptibility. To advance interpretations of disease-related patterns of fundus AF in AMD, 
we also consider the photochemical and spectrophotometric features of the lipofuscin 
compounds responsible for generating the fluorescence emission.  
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Age-related macular degeneration (AMD) is a complex disorder that is influenced by genetic and 
environmental factors; heritability is estimated to account for 45% to 71% of cases [1,2]. Several (~20) 
AMD genetic susceptibility genes have been identified with two loci, complement factor H (CFH 
(1q32) and age-related maculopathy susceptibility 2/HtrA serine peptidase 1 (ARMS2/HTRA1) on 
10q26 accounting for 50% of AMD cases [3,4]. The CFH locus harbors many independent risk and 
protective haplotypes [5,6] while for ARMS2/HTRA1 a single major risk haplotype is associated with 
AMD [7]. Multiple studies have also demonstrated that haplotype-tagging single-nucleotide 
polymorphisms (SNPs) in CFH and ARMS2, are major determinants of AMD endophenotypes and 
disease progression [8]. Specifically, CFH-rs1061170 is associated with drusen and with both early and 
advanced AMD while ARMS2-rs10490924 is strongly associated with reticular pseudodrusen and 
rapid progression to late AMD [5,7–9]. Nevertheless, by various estimates, currently known genetic loci 
account for only 50%–75% of overall AMD risk. Interest in a role for retinal pigment epithelium (RPE) 
lipofuscin in AMD stems from the knowledge that it accumulates with age [10,11], is high in central 
retina [11], exhibits behaviors toxic to RPE [12–15] and exhibits a link to drusen formation [16].  
2. RPE Lipofuscin as the Source of Short-Wavelength (SW)-Fundus Autofluorescence 
Advances in non-invasive fundus imaging have facilitated the diagnosis and differentiation of 
retinal disease. In vivo imaging provides a window within which to view the natural course of retinal 
disease. Of the available imaging modalities, fundus autofluorescence (AF) has proven to be especially 
valuable, in large part because disease-related processes can alter the distribution of the AF signal. 
Accordingly, recognizable disease phenotypes are often produced.  
The natural autofluorescence of the fundus that is excited by SW light (488 nm excitation) (Figure 1) 
exhibits spectral features and an age-relationship that indicates a principle origin from the fluorescent 
pigments that accumulate in RPE cells as lipofuscin [17]. Unlike lipofuscin species that accumulate in 
other non-dividing cells, the pigments of RPE lipofuscin are produced in the membranes of photoreceptor 
outer segments from non-enzymatic reactions of vitamin A aldehyde [18–21]. This fluorescent material 
is transferred to RPE cells within phagocytosed outer segment disks [22,23] and becomes deposited in 
the lysosomal compartment of the cells. In the healthy retina, fundus autofluorescence increases 
linearly with age although subjects vary in terms of intensities [11]. The age-related increase levels off 
after age 70 perhaps because of a loss of photoreceptor or RPE cells [24] and/or changes in fluorescence 
emission due to extensive photooxidation/photodegradation of the bisretinoid compounds [25] 
(discussed below).  
RPE lipofuscin consists of a complex mixture of fluorophores that have been identified in by 
chromatography and mass spectrometry and characterized structurally; all of the known bisretinoid 
lipofuscin pigments have been detected in human eyes [26] (Figure 2). These fluorophores include the 
pyridinium-containing molecules A2-glycerophosphoethanolamine (A2-GPE) [27], A2E and isomers 
of A2E [28–36], dimers of all-trans-retinal having a cyclohexadiene head group (all-trans-retinal 
dimer) [33,37] and the associated protonated Schiff base conjugate [37] and the uncharged A2-DHP-PE 
(A2-dihydropyridine-phosphatidylethanolamine) [38]. Higher molecular weight adducts also form 
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when aldehyde-bearing cleavage products of bisretinoid react with intact bisretinoid molecules [39]. 
Other molecular constituents of RPE lipofuscin are adducts of CEP (2-(ω-carboxyethyl)-pyrrole) [40], 
HNE (4-hydroxynonenal) and MDA (malondialdehyde) [41] that are derived from oxidative 
fragmentation of lipid. Products of lipid oxidation are generally non-fluorescent or blue-emitting 
fluorophores [42,43] and in this case could be generated by the photoreactivity of other lipofuscin 
fluorophores. Little or no protein is present in RPE lipofuscin [40]. Accumulation of bisretinoids in 
RPE cells is unlikely to depend on an inhibition of lysosomal enzyme activity, since this fluorescent 
material is amassed in all healthy eyes beginning at early ages [44]. 
Figure 1. Short-wavelength (SW-AF) and near-infrared (NIR-AF) fundus autofluorescence. 
Images were obtained with 488 nm (SW) and 787 nm (NIR) excitation. 
 
Figure 2. Structures and absorbance maxima (λmax) of some bisretinoid fluorophores  
in retinal pigment epithelium (RPE) lipofuscin. Absorbance maxima can be assigned to 
each of the side-arms of the molecules.  
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The various bisretinoids of RPE lipofuscin have some common structural features (Figure 2). They 
present with a central six-carbon ring from which extend two polyene arms terminating in β ionone 
rings. Each of these arms is derived from a molecule of retinaldehyde and constitutes a separate  
light-absorbing chromophore, one arm absorbing in the ultraviolet range and the other in the visible 
(Figure 2). The numbers of alternating carbon-carbon double and single bonds that form the 
conjugation systems of the arms determine the wavelength of absorbance; the longer conjugation 
system in each molecule confers absorbance in the visible range. Absorbances in the visible spectrum 
are significant since these wavelengths reach the retina. Since these adducts of retinaldehyde are held 
together by covalent bonds, bisretinoids do not provide stores of retinoid for the visual cycle, as has 
been suggested [45]. 
3. Spectral Signatures of SW-Fundus AF and RPE Lipofuscin 
In clinical settings, SW-fundus AF is excited by wavelengths ranging from 488 nm, the excitation 
employed with a confocal scanning laser ophthalmoscope (cSLO), to the 535–580 nm range utilized  
by a modified fundus camera [46] and the 568 nm light used with fluorescence adaptive optics 
ophthalmoscopy [17,47,48]. Fundus autofluorescence measured in vivo by spectrophotometry has a 
broad excitation spectrum that peaks between 490–510 nm. The fluorescence emission is also broad 
and centered at approximately 600 nm [11,17]. RPE lipofuscin ex vivo exhibits an excitation spectrum 
that peaks between 450–490 nm; the fluorescence emission is maximal at ~600 nm [49] (Figure 3). 
Moreover, just as with fundus autofluorescence, the emission spectrum recorded from whole lipofuscin 
exhibits red-shifts when excited by progressively longer wavelengths [49] (Figure 3). Thus the spectral 
characteristics of fundus autofluorescence are consistent with that of RPE lipofuscin [43,50–52] and 
chiefly with an origin from the bisretinoid fluorescent pigments that are known constituents of  
RPE lipofuscin. The bisretinoids that have been characterized have absorbance maxima varying from 
440 nm to 510 nm and they emit with an orange fluorescence that peaks at ~600 nm [26]. The 
bisretinoid A2E can emit fluorescence at longer wavelength excitations such as 545 nm (Figure 3B). 
Figure 3. Fluorescence emission spectra of human RPE lipofuscin and A2E (in PBS with 
2% DMSO). Emission was recorded at excitation wavelengths 436, 480 and 545 nm as 
published [49]. Emission maxima are indicated.  
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4. Photoreactive Properties of RPE Lipofuscin and the Implications for Fundus AF  
While there exists no evidence that bisretinoids of RPE lipofuscin can undergo lysosomal 
degradation, loss of this material due to photodegradation has been demonstrated. Thus studies of RPE 
lipofuscin [53–55] and individual bisretinoid lipofuscin fluorophores such as A2-GPE, all-trans-retinal 
dimer and A2E have revealed that these compounds are photoinducible generators of reactive oxygen 
species such as singlet oxygen and superoxide anion. Singlet oxygen in turn reacts with the conjugated 
double bond systems comprising the arms of the bisretinoid molecules [56–61] leading to the 
fragmentation of the parent molecules and release of aldehyde-bearing cleavage products such as 
methylgloxal and glyoxal [60] that can react with and inactivate proteins. These small dicarbonyls also 
provoke the formation of advanced glycation end products (AGE) that deposit extracellularly [16,62].  
AGEs incite inflammatory processes and since they are detected in drusen [63,64], they reflect a 
link between RPE bisretinoid lipofuscin and the formation of sub-RPE deposits. Photooxidation of 
A2E and all-trans-retinal dimer has also been shown to incite complement activation [65,66]. 
Photooxidation is clearly an ongoing process in the eye since photooxidized forms of A2E and  
all-trans-retinal dimer have been detected in isolated human and mouse RPE [25,57]. These processes 
likely contribute to Bruch’s membrane thickening [67] and photoreceptor cell degeneration [68,69] in 
Abca4 mutant mice and are a cause of the increased vulnerability of albino Abca4−/− mice to retinal 
light damage [70]. 
The propensity for bisretinoids to undergo photooxidative and photodegradative processes may 
underlie the decline in RPE lipofuscin fluorescence emission (photobleaching) that has been  
observed in non-human primates during in vivo fluorescence imaging by adaptive optics scanning laser 
ophthalmoscopy [48,71], with cell culture models [72] and in non-cellular assays (Figure 4). 
Lipofuscin photobleaching may also explain why after surgical repair of some cases of retinal 
detachment, hyperautofluorescent lines coursing parallel to retinal blood vessels can be visible in 
fundus AF images [73,74] (Figure 5). The hyperautofluorescent imprint has been interpreted as 
indicating a change in the position of the vessel relative to the underlying retinal tissue and is  
visible because of contrasting levels of AF brightness. At any given time, the intensity of fundus AF is 
likely the difference between fluorophore synthesis on the one hand, and lipofuscin photoxidation/ 
photodegradation in RPE, on the other. Under the shadow of a blood vessel, the formation of 
bisretinoid from retinaldehyde (with 11-cis being converted to all-trans-retinal) would likely continue 
unabated [20,30,75–77] but lipofuscin photooxidation and photobleaching would be substantially 
reduced. As a result, a vessel imprint of more intense AF would be revealed upon retinal translocation. 
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Figure 4. A2E photobleaching by irradiation at 480 nm for 4 and 8 min. Fluorescence 
intensity decreases with irradiation and the emission maximum undergoes a hypsochromic 
shift. Emission peak wavelengths (nm) are indicated adjacent to each trace.  
 
Figure 5. Fundus autofluorescence image of an individual following retinal detachment 
repair. Hyperautofluorescent lines follow a course that parallels the retinal vessels below.  
 
5. Topographic Distribution of SW-AF in Healthy Eyes 
When RPE lipofuscin is assayed by recording fluorescence in histological sections of human retina, 
the signal is found to increase from central fovea to perifovea and after peaking at an eccentricity  
of ~8°, it decreases towards the periphery [10,78]. A similar pattern has been observed with quantitative 
fundus autofluorescence (qAF) (Figure 6); at an eccentricity of 10°, qAF is approximately 95% of that 
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measured centrally [79]. Reduced foveal fundus autofluorescence is due in large part to absorption of 
the exciting light by macular pigment and to the higher optical density of melanin in central RPE [17]. 
By fundus spectrophotometry, qAF and fluorescence photomicroscopy [45], the highest levels of RPE 
lipofucin in healthy eyes have been observed perifoveally in superior-temporal retina (Figure 6) [44]. 
Unexpectedly, this pattern was not replicated in another study relying on fluorescence measurements 
in flat-mounted human cadaver eyes [80].  
Figure 6. Quantitative fundus autofluorescence (qAF) in healthy human eyes.  
Short-wavelength fundus AF images (top row) and corresponding color-coded qAF images 
(bottom row) at the ages indicated. Lower qAF values are coded in blue and higher qAF 
values as orange (color scale). Fundus autofluorescence intensities increase with age and 
the highest levels occur in superior-temporal fundus.  
 
Based on the spatial distribution of mass peaks detected with matrix-assisted laser desorption-ionization 
imaging mass spectrometry (MALDI-MS) investigators have reported that A2E is detectable in central 
retina of mice [81], but not in the central human RPE [36]. Instead, the highest A2E levels were 
restricted to a small patch of RPE found exclusively in the far periphery of temporal retina [80]. This 
patch was not matched by similar A2E signal in in the periphery of superior, nasal or inferior retina. 
While A2E is well known to be fluorescent, surprisingly, this patch was almost devoid of fluorescence. 
Since the spectral features of RPE lipofuscin and fundus autofluorescence are best accounted for by 
the excitation and emission spectra of the bisretinoid constituents, the fluorescence originating in 
centrally situated RPE cells likely originates from some combination of these di-retinal adducts. 
Interestingly, the MALDI-MS findings could indicate that the various species of bisretinoid lipofuscin 
compounds exhibit spatial heterogeneity. Reduced levels of A2E in the macula could also be a 
consequence of greater lipofuscin photocleavage in central RPE; an explanation such as this could 
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account for the greater susceptibility of the macula to disease. Failure to detect A2E centrally, may 
even be attributable to the limitations of the methodology. MALDI-MS is a surface-based technique 
that depends on the extraction of analyte into a matrix applied to the surface of the tissue. Factors that 
could cause spatial differences in extraction efficiency are regional differences in RPE height and 
spatial differences in the compartmentalization of lipofuscin. For instance RPE cells are taller and 
narrower in the human macula [78] with melanin being uppermost and lipofuscin at greater depths in 
the cells. After age 50 complex organelles containing both melanin and lipofuscin (melanolipofuscin) 
predominate in the cells [78] with macular RPE containing more melanolipofuscin than RPE at the 
equator and periphery [82]. Lipofuscin is less extractable from the RPE of these older eyes [83]. Thus 
it is likely that the extraction from central RPE is less efficient because of the depths of lipofuscin in 
the cells and/or difficulty in accessing lipofuscin from complex melanolipofuscin-organelles. 
6. NIR-AF in the Healthy Eye 
The healthy fundus also exhibits a near-infrared autofluorescence (NIR-AF) (>800 nm) when 
excited at ~787 nm [84,85] (Figure 1). The intensity of the fundus NIR-AF is at least 60 times less than 
SW-AF [86]. Several lines of evidence indicate that RPE and choroidal melanin serve as a source of 
the NIR-AF signal. For instance, melanin is known to fluoresce under near-infrared light excitation [87]. 
Additionally, the high NIR-AF signal at the fovea corresponds [86] to the elevated optical density of 
melanin in this area [78]. Melanocytic choroidal nevi also fluoresce brightly with NIR-AF imaging. 
Conversely, NIR-AF emanating from a full-thickness macular hole is similar in brightness to 
surrounding retina [86].  
The more frequent use of SW-AF may be due, in part, to the introduction of the Heidelberg 
Spectralis having optical coherence tomography (OCT) capability (HRA + OCT) and to the 
subsequent decline in the popularity of the HRA2 and Spectralis HRA in retinal clinics. The OCT 
module in the Spectralis reduces NIR-AF signal intensity, thus compromising NIR-AF image quality 
as compared to cSLOs without OCT (e.g., HRA2 and Spectralis HRA). Nevertheless, NIR-AF has 
advantages over SW-AF. For instance, during image acquisition, patients are not disturbed by the  
NIR-AF light as they are with the SW-AF exciting light. This improves patient cooperation, especially 
in young children and photophobic patients.  
7. Comparison of SW- and NIR-AF in AMD: Altered Intensities and Aberrant Patterns  
In the presence of retinal disease such as AMD, patterns and intensities of fundus autofluorescence 
are notably altered [88–93]. At locations of RPE and photoreceptor cell demise (atrophy) both the  
SW-AF and NIR-AF signals become strikingly deficient or absent [94,95]. These areas of atrophy can 
take the form of discrete spots, isolated patches or large expanses (geographic atrophy, GA, USA). 
Loss of the RPE cell monolayer in GA has been confirmed by OCT [96]. While GA presents as areas 
of darkness in both SW and NIR-AF (Figure 7), the lesion size can sometimes appear larger with either 
the SW-AF or NIR-AF modality [84,97] (Figure 7). Nevertheless, the rate of increase in GA area is the 
same whether measured in SW- or NIR-AF images [98]. In exudative AMD, the developing 
neovascular lesion can be discerned in SW-AF images early on as a focal hyperautofluorescence [99]. 
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Later the SW-AF signal is reduced within the lesion [99,100]. In some cases the edge of the 
neovascular lesion exhibits increased SW-AF signal [100]. 
In the zone of retina immediately adjacent to geographic atrophy, there are often additional AF 
changes. These aberrant signals can present as intermittent foci or continuous bands of altered 
brightness in both SW-AF and NIR-AF images [101–103]. In these junctional zones areas of increased 
SW-AF can coincide with increased NIR-AF; increased SW-AF can overlap with reduced NIR-AF; or 
NIR-AF signal can be enhanced while SW-AF may appear normal [84,104] (Figure 7). Interestingly, a 
loss of photoreceptor function was found to be associated with both increased and decreased  
NIR-AF [97,105].  
Since both SW-AF and NIR-AF are considered to originate in RPE cells, it is puzzling that SW-AF 
can be increased at positions where NIR-AF is reduced or absent. This apparent incongruity has been 
attributed to abnormal RPE cells that have lost melanin while accumulating excessive levels of 
lipofuscin due to accelerated rates of outer segment phagocytosis [84,105]. However, lipofuscin 
production is not dependent on the rate of phagocytosis. The lipofuscin forms in photoreceptor cells 
prior to disc shedding and phagocytosis. As is evident from studies of the RCS rat, the fluorophores of 
lipofuscin form and accumulate in photoreceptor outer segment debris even in the absence of 
phagocytosis [106–108].  
Other observations indicate that photoreceptor cells are likely to be degenerating in these junctional 
zones of increased SW-AF. In particular, retinal sensitivity, measured by microperimetry, is commonly 
reduced at positions presenting with increased SW-AF as compared to normal SW-AF [105,109]. In 
addition, OCT findings in the zone of enhanced autofluorescence surrounding GA include thinning of 
the reflective band attributable to RPE/Bruch’s membrane and disruption of the reflectivity band 
corresponding to the ellipsoid zone of photoreceptor inner segments [96,110] Thus could it be that at 
positions of diminished NIR-AF, RPE cells are atrophied or lost and impaired photoreceptor cells 
become a source of accelerated lipofuscin formation and thus enhanced SW-AF? Mechanistically, 
mishandling of retinaldehyde, the precursor of lipofuscin, is known to lead to elevated bisretinoid 
formation in photoreceptor cells [111] and compromised photoreceptor cells may not be able to 
provide the energy needed for reduction of retinaldehyde to the non-reactive alcohol form. Similar 
mechanisms may explain the rapid onset of elevated fundus SW-AF that co-localizes with scotomas 
associated with acute macular neuroretinopathy (AMN) [93,112].  
The observation that NIR-AF signals increase in parallel with increases in SW-AF at the border of 
GA may also not be fully understand. Hyperautofluorescence foci at the junctional zone of GA, at least 
in some cases, can be attributed to abnormally superimposed RPE cells [113,114]. But whether this 
can account for more extensive bands of high NIR-AF [84] is not certain. It has been suggested that 
RPE lipofuscin may contribute to NIR-AF of the fundus [86]. However, albino rats do not exhibit 
NIR-AF despite the presence of lipofuscin [115] and as shown in Figure 8, we have not detected an 
NIR-AF signal from synthesized samples of A2E that otherwise emit fluorescence when excited at  
488 nm. NIR-AF emission from other bisretinoids is unlikely, given the small structural differences 
amongst these compounds (Figure 2). If melanogenesis is the basis for increased NIR-AF brightness at 
the border of GA, as has been suggested [84,105], one might expect that increased melanin concentrations 
would be visible as hyperpigmented spots and bands in color fundus photographs. In considering an 
optical effect as an explanation for increased NIR-AF signal it could be that RPE lipofuscin does not 
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fluoresce in the NIR range but can modify the NIR-AF emission from melanin. This could occur if 
lipofuscin secondary lysosomes intercalate amongst apically situated melanosomes [78,116] thereby 
reducing the NIR-AF quenching associated with secondary self-absorbance of the fluorescence 
emission. A mechanism such as this might also explain why hyperautofluorescent rings visible in the 
NIR-AF fundus images in retinitis pigmentosa exhibit spatial correspondence with high intensity rings 
observed in SW-AF images [117]. 
Figure 7. An area of geographic atrophy (GA) imaged with short-wavelength (SW) and 
near-infrared (NIR) autofluorescence (AF) imaging. GA appears dark with both modalities. 
The zone surrounding GA is hyperautofluorescent in the NIR-AF image while having 
relatively normal SW-AF signal. When vessel landmarks are used as a guide (arrows), total 
lesion size appears larger in the NIR-AF image. 
 
Figure 8. Synthesized A2E imaged with a confocal scanning laser ophthalmoscope 
(HRA2; Heidelberg Engineering, Heidelberg, Germany) using 488 nm (SW-AF) and 787 nm 
(NIR-AF) excitation. No signal was generated with the NIR excitation. 
 




Interest in a role for RPE lipofuscin in AMD stems from its age-related increase [10,11], an 
accumulation that is more pronounced in central retina [11], a propensity for adverse effects on RPE 
and photoreceptor cells [12–15,68,70] and links to drusen formation [16,67]. Contributions to AMD 
susceptibility from RPE lipofuscin would exist within the context of background genetic risk. Thus 
extrapolation from aging eyes in the absence of disease may not be informative [45].  
Since the products of bisretinoid photodegradation can be damaging [16,60], it is worth considering 
whether lipofuscin lost by photooxidation/photodegradation is more significant than the lipofuscin 
remaining in the cells. At any given time, the lipofuscin in RPE that is recorded by SW-AF may 
consist of only some portion of the fluorescent material that has been accumulated over a life-time. 
SW-AF emitted from RPE bisretinoids is commonly regarded as a way to monitor the health of the 
RPE, with areas of high AF indicating increased lipofuscin levels and areas of low AF indicating RPE 
loss. However, as discussed here there is increasing evidence that interpretations of the SW-AF signal 
are complex. For instance, impaired photoreceptors may generate increased levels of bisretinoid 
fluorophores thus amplifying SW-AF signal. Ultimately, an understanding of patterns of fundus AF 
will impact the use of these images to assess therapeutic outcomes. 
While fundus autofluorescence provides en face spatial information, the spectral features of the 
fluorescence are not elucidated and the cellular origin of the fluorescence is not identified. Recently, 
however, methods have been developed for quantifying SW-AF. This approach has been shown to 
enable the differentiation of similar phenotypes having disparate genetic origins [44,118]. The qAF 
approach may eventually help to ascertain the role of lipofuscin in various retinal disorders including 
AMD. Because of more limited gradations of signal and thus greater contrast, diseased versus  
non-diseased areas of retina are easier to distinguish in NIR-AF images as compared to SW-AF 
images. Indeed, in recessive Stargardt disease (STGD1), SW-AF changes are often not obvious at 
fundus locations where abnormalities are detectable in NIR-AF images [119]. In addition, in many 
cases the low NIR-AF signal corresponds spatially to loss of the inner segment ellipsoid zone (EZ) in 
spectral domain (SD) OCT images [119]. This relationship is important since EZ integrity is essential 
for visual function [120]. While the origin of the NIR-AF signal may not be completely understood, 
the NIR-AF signal can provide a good estimate of the size of geographic atrophy and surrounding 
abnormalities. All of these issues favor the inclusion of NIR-AF in the management of retinal diseases 
such as AMD. 
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